Cancer Letters: Multi-omics immune classification reveals immunotherapy opportunities in colorectal cancer
Our team published MotifCC in Cancer Letters, a multi-omics immune classification framework for colorectal cancer that links tumor heterogeneity to prognosis and immunotherapy …

























